A 11 year-old boy with diffuse intrinsic pontine glioma (DIPG)…
Cancer History:
First diagnosis of cancer: 12/2018 cancer type: midline glioblastoma; stage IV
Refractory or persistent disease sites: Pons
Therapy gone through: Surgery: Yes (with residual)
Chemotherapy 2 cycles temozolomide regimen; radiotherapy: Yes (5400cGy/30f/41d)
Targeted drugs: no immunotherapy: no others: no
Clinical Trial Number: NCT03170141; enrolled date: 24/04/2019
Interventions: CART (GD2, PSMA) after lymphodepletion with Flu-Cy
CRS Grade: 1 ; other side effects: no
Treatment response: CR (after CAR-T infusion 36 days)
Quality of Life: Improved
Current status: No evidence of disease
Disease images before and after CART treatment
Copyright © 2016 Shenzhen Genoimmune Medical Institute all rights reserved.